Top Markets
Coin of the day
Gujarat Themis Biosyn Ltd. Gujarat Themis Biosyn Ltd.

Gujarat Themis Biosyn Ltd.

GUJTHEM
Rang in Aktien #13260
Gujarat Themis Biosyn Ltd. is an Indian company primarily involved in the... Gujarat Themis Biosyn Ltd. is an Indian company primarily involved in the creation of pharmaceuticals and medicinal chemicals. The firm also supplies bulk drugs via a job work model within India. Its product offerings include important compounds such as Rifamycin-S, an intermediate used in treatments for tuberculosis, Mycobacterium avium complex, leprosy, and Legionnaires' disease. Another key product, Rifamycin-O, addresses ailments like traveler's diarrhea, irritable bowel syndrome, and hepatic encephalopathy. Furthermore, they produce Lovastatin. Established in 1981, the company's operations are based out of Mumbai, India.
Aktienkurs
$4.66
Marktkapitalisierung
$507.71M
Veränderung (1 Tag)
2.94%
Veränderung (1 Jahr)
8.43%
Land
IN
Handel Gujarat Themis Biosyn Ltd. (GUJTHEM)

Kategorie

Dividendenrendite-Verlauf für Gujarat Themis Biosyn Ltd. (GUJTHEM)
Dividendenrendite (TTM) von Gujarat Themis Biosyn Ltd. (Aktienkürzel: GUJTHEM) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für Gujarat Themis Biosyn Ltd. (GUJTHEM) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber